Three products, one carbon skeleton, one methyl group between each of them. Piperazine (CAS 110-85-0), N-methylpiperazine (CAS 109-01-3) and N,N-dimethylpiperazine (CAS 106-58-1) look interchangeable on a catalogue page and are not. The difference is how many of the two ring nitrogens are still secondary, and that single number decides what the molecule can do.
This note sets them side by side, explains why the middle member of the series is the commercially interesting one, and lists the naming and numbering confusions that put the wrong drum on the truck.
The series
| Property | Piperazine | N-Methylpiperazine | N,N-Dimethylpiperazine |
|---|---|---|---|
| CAS | 110-85-0 | 109-01-3 | 106-58-1 |
| Formula / MW | C4H10N2 / 86.14 | C5H12N2 / 100.16 | C6H14N2 / 114.19 |
| Nitrogens | Two secondary | One secondary, one tertiary | Two tertiary |
| Appearance | White crystalline solid | Colourless to yellowish liquid | Colourless liquid |
| Boiling point | About 146 deg C | About 138 deg C | About 130 deg C |
| Reactivity toward acylation and alkylation | Both nitrogens react – mixtures | Only one nitrogen reacts – single products | Essentially unreactive at nitrogen |
The pattern is straightforward: each methyl removes one reactive nitrogen and adds one small, non-reactive, basic centre. Moving along the series trades functionality for inertness.
Why the middle member is the valuable one
Piperazine is the cheap commodity. Dimethylpiperazine is a specialty solvent and catalyst intermediate. N-Methylpiperazine sits between them and is usually the most expensive of the three per kilogram, because it is the hardest to make: the methylation has to stop after one step, and the three amines that result have boiling points within about 16 deg C of each other.
That combination – difficult separation, high value per kilogram – is why the specification limits on N-methylpiperazine are so tight and so symmetric:
| Impurity | What it is | Why 0.10% |
|---|---|---|
| Piperazine, max 0.10% | Unreacted starting material | The under-methylated side: incomplete conversion, or a column that is not taking the higher boiler overhead |
| N,N-Dimethylpiperazine, max 0.10% | The over-methylated homologue | The over-reacted side: poor selectivity, or a column that is not taking the lower boiler out of the bottoms |
Both ceilings at the same figure is the signature of a plant that has both ends of the distillation under control. A certificate with a single “related substances: 0.5% max” line tells a buyer nothing about which of the two failure modes they are buying.
Choosing between them
| If the requirement is | Then the product is | Because |
|---|---|---|
| Attach a piperazine ring at exactly one point | N-Methylpiperazine | The methylated nitrogen cannot react, so no bis-product forms |
| A basic centre with no reactive nitrogen at all | N,N-Dimethylpiperazine | Both nitrogens are tertiary; a non-fugitive catalyst or a non-reactive base |
| A cheap diamine for salt formation, curing or gas treating | Piperazine | Cheapest per mole of amine; the symmetry costs nothing in those uses |
| A ring-methylated chiral scaffold | 2-Methylpiperazine (109-07-9) | Methyl on a carbon gives a stereocentre; both nitrogens stay secondary |
| An amine that reacts into a polymer and also catalyses it | N-Methylpiperazine | Secondary amine reacts, tertiary nitrogen catalyses – the reactive-catalyst case |
Where the three overlap in practice
In rigid polyurethane foam, all three appear in the catalyst toolbox, and they are not equivalent:
- N,N-Dimethylpiperazine catalyses the isocyanate-alcohol reaction and stays in the foam as a mobile molecule – it plasticises, it can migrate, and it contributes to emissions. Cheap and effective, with a known downside.
- N-Methylpiperazine does both jobs: the secondary nitrogen reacts into the polymer network while the tertiary nitrogen catalyses. A reactive catalyst that does not migrate. This is worth a price premium in applications where fogging or emissions are regulated.
- Piperazine is too reactive and too difunctional for this use – it reacts twice and stiffens the network, so it appears in different roles entirely.
The same logic appears in pharmaceutical routes: a chemist who needs a piperazine in the final molecule for its basicity will usually pick N-methyl, because a free secondary nitrogen in a drug candidate will react with everything in the body and with the excipients in the formulation.
Naming and numbering traps
These are real purchase-order hazards, not pedantry:
| Trap | What happens |
|---|---|
| N-Methylpiperazine vs 2-methylpiperazine | Different CAS (109-01-3 vs 109-07-9), different reactivity. The first has a methyl on nitrogen; the second on carbon |
| N-Methylpiperazine vs N,N-dimethylpiperazine | One character apart in a catalogue; completely different reactivity at nitrogen |
| “Methylpiperazine” alone | Ambiguous – it can mean N-methyl or any ring-methyl isomer. Always quote the CAS |
| 1-Methylpiperazine vs 4-methylpiperazine | The same compound, since the ring is symmetric – but a catalogue may list only one of the two names |
| Piperazine hydrate vs anhydrous | Piperazine is often supplied as the hexahydrate; the assay basis changes accordingly |
Buying notes
- Quote the CAS on the purchase order. All the ambiguities above disappear with four numbers.
- Ask for the two piperazine impurities separately for N-methylpiperazine, not an aggregate.
- Check the water figure on all three: they are water-miscible and hygroscopic, and water is the figure that moves in storage.
- Treat dimethylpiperazine as a co-product, not a waste if you are buying volume – a producer running the full series can supply all three from one column train.
Product pages
Specifications for piperazine (CAS 110-85-0) and for N-methylpiperazine (CAS 109-01-3) are available from the same supply chain; N,N-dimethylpiperazine is available to order. The application side of the middle member is covered in our note on N-methylpiperazine in pharmaceutical intermediates and PU catalysis.
Disclaimer. This comparison describes structure-property differences between three commercial products. It is not a recommendation for a specific formulation: catalyst selection in polyurethane and route selection in pharmaceuticals are established by experiment against the buyer’s own system.
For samples of the series side by side, certificates with the individual piperazine figures, or pricing on drums and IBCs, contact PolyBlueChem.